Back to Results
First PageMeta Content
Alkylating antineoplastic agents / Nitrogen mustards / Organochlorides / Asbestos / Mesothelioma / Cyclophosphamide / Ifosfamide / Chemotherapy / Medicine / Chemistry / Oncology


Document Date: 2010-10-19 13:01:09

Open Document

File Size: 39,99 KB

Share Result on Facebook

City

ATLANTA / /

Company

ZIOPHARM Oncology Inc. / Contact Investors ZIOPHARM Oncology Inc. / /

Continent

Europe / /

Country

United States / /

/

Event

FDA Phase / /

IndustryTerm

biopharmaceutical / cancer therapies / /

MedicalCondition

cancers / cancer / lymphoma / approved cancer / approved and developmental cancer / human cancer / stable disease / progressive cancers / advanced sarcoma / children's cancers / /

MedicalTreatment

cancer therapies / /

Organization

American Society / /

Person

Robert Peter Gale / Kelly Luethje / Kathryn Morris / /

/

Position

lead author and Senior Vice President of Research / /

Product

mesna / cyclophosphamide / ifosfamide / ZIO-201 / /

URL

www.ziopharm.com / http /

SocialTag